Navidea Biopharmaceuticals, Inc. (NAVB)
1.6500 -0.01 (-0.60%)
After hours: 4:01PM EDT
Chart Events
Performance Outlook
| Previous Close | 1.6900 |
| Open | 1.6700 |
| Bid | 1.6500 x 1000 |
| Ask | 1.6900 x 1800 |
| Day's Range | 1.6600 - 1.7500 |
| 52 Week Range | 0.6300 - 5.3600 |
| Volume | 123,643 |
| Avg. Volume | 377,934 |
| Market Cap | 49.119M |
| Beta (5Y Monthly) | 1.83 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4760 |
| Earnings Date | Mar 24, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Related Research
- Business Wire
Navidea Biopharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced its financial results for the fourth quarter and full year for the period ended December 31, 2020.
- ACCESSWIRE
Navidea Biopharmaceuticals, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / March 24, 2021 / Navidea Biopharmaceuticals, Inc. (AMEX:NAVB) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 24, 2021 at 5:00 PM Eastern Time.
- Business Wire
Navidea Biopharmaceuticals to Host Fourth Quarter 2020 Earnings Conference Call and Corporate Update
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced it will host a conference call and webcast on Wednesday, March 24, 2021 at 5:00 p.m. (EDT) to discuss financial results and corporate developments for the fourth quarter ended December 31, 2020.
